Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Social Networks
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. Hosting Providers
  14. CDN Services

We began analyzing https://www.dovepress.com/role-of-micrornas-in-hepatocellular-carcinoma-a-clinical-perspective-peer-reviewed-fulltext-article-OTT, but it redirected us to https://www.dovepress.com/role-of-micrornas-in-hepatocellular-carcinoma-a-clinical-perspective-peer-reviewed-fulltext-article-OTT. The analysis below is for the second page.

Title[redir]:
Role of microRNAs in hepatocellular carcinoma: a clinical perspective | OTT
Description:
Role of microRNAs in hepatocellular carcinoma: a clinical perspective Elisa Callegari,1 Bahaeldin K Elamin,1,2 Silvia Sabbioni,3,5 Laura Gramantieri,4 Massimo Negrini1,5 1Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università di Ferrara, Ferrara, Italy; 2Department of Microbiology, Faculty of Medical Laboratory Sciences, University of Khartoum, Sudan; 3Dipartimento di Scienze della Vita e Biotecnologie, Università di Ferrara, Ferrara, 4Centro di Ricerca Biomedica Applicata e Dipartimento di Medicina Interna, Policlinico S Orsola-Malpighi e Università di Bologna, Bologna, 5Tecnopolo "Laboratorio per le Tecnologie delle Terapie Avanzate", Università di Ferrara, Ferrara, Italy Abstract: Hepatocellular carcinoma (HCC) is one of the most deadly tumors, and current treatments for the disease are often ineffective. The discovery of the involvement of microRNAs (miRNAs) in hepatocarcinogenesis represents an important area of investigation for the development of their clinical applications. These molecules may act as oncogenes or tumor suppressors by directly or indirectly controlling the expression of key proteins involved in cancer-associated pathways. On the clinical side, because of their tumor-specific expression and stability in tissues and in the circulation, miRNAs have been proposed as novel diagnostic tools for classification and prognostic stratification of HCC. In recent years, the therapeutic potential of miRNAs has been demonstrated in various preclinical studies. Anti-miRNA oligonucleotides and miRNA mimics have been found to have antitumor activity. Moreover, by exploiting tumor-specific expression of miRNA, efforts have been aimed at improving targeting of tumor cells by replicative oncolytic viruses while sparing normal cells. These areas are expected to be explored further in the upcoming years to assess the clinical value of miRNA-based approaches in HCC and cancer in general. Keywords: hepatocellular carcinoma, microRNA, micromarkers, oncolytic viruses

Matching Content Categories {📚}

  • Science
  • Education
  • Insurance

Content Management System {📝}

What CMS is doi.org built with?

Custom-built

No common CMS systems were detected on Doi.org, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 93,526,998 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We see no obvious way the site makes money.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

medical, press, dove, ferrara, authors, work, open, review, published, learn, clinical, università, terms, informa, reprints, access, journals, peer, hepatocellular, carcinoma, permission, article, dipartimento, hcc, mirnas, expression, plc, contact, testimonials, favored, author, login, scientific, papers, manuscript, volume, micrornas, callegari, elamin, sabbioni, gramantieri, negrini, download, pdf, medicina, italy, bologna, tumor, tumorspecific, years,

Topics {✒️}

including fast-track processing dove medical press manuscript login exploiting tumor-specific expression favored authors specific author medical laboratory sciences offer real benefits key proteins involved author academic publishing division london sw1p 1wg uk vat group università di ferrara università di bologna sparing normal cells tumor-specific expression anti-mirna oligonucleotides mirna-based approaches papers review replicative oncolytic viruses articles published informa plc medical journals tumor cells published medicina sperimentale tumor suppressors full terms journals » oncotargets clinical applications clinical side mirna mimics scientific journal alerts pharmaceutical industry hepatocellular carcinoma s36161 checked 4 massimo negrini1 orsola-malpighi deadly tumors current treatments hepatocarcinogenesis represents important area indirectly controlling diagnostic tools prognostic stratification recent years therapeutic potential

Questions {❓}

  • Why publish with us?

Social Networks {👍}(9)

External Links {🔗}(51)

Analytics and Tracking {📊}

  • Google Analytics
  • Google Analytics 4
  • Google Tag Manager
  • Google Universal Analytics

Libraries {📚}

  • jQuery

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Com/cm/ef49a3f1-d8c1-47d6-88fc-50e41130631f/airgap

6.14s.